Eli Lilly European Clinical Trial Services SA
32.8 FTEEli Lilly European Clinical Trial Services reported revenue of €270.4m for the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026), with 32.8 full-time equivalents.
By total assets for 2025, Eli Lilly European Clinical Trial Services ranks among the 10 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Eli Lilly European Clinical Trial Services shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +16 % Equity -6 % Total assets +2 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eli Lilly European Clinical Trial Services's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Eli Lilly European Clinical Trial Services's financial analysis
- Solvency8.6%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eli Lilly European Clinical Trial Services
4 active director(s) in the register.
Eli Lilly European Clinical Trial Services's shareholders and holdings →Eli Lilly European Clinical Trial Services's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0888.210.786
- VAT number
- BE0888210786
- Peppol
- Registered · 0208:0888210786 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Mar 2007
- Registered office
- 1435 Mont-Saint-Guibert
- Size
- Small · 32.8 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Eli Lilly European Clinical Trial Services (SA) has been based in Mont-Saint-Guibert since 2007, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports revenue of €270.4m, a net profit of €13.9m and equity of €4.96m. With 32.8 full-time equivalents, it is a small enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eli Lilly European Clinical Trial Services
Companies in the same business, of comparable size and area, outside its group.
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline Wholesale of pharmaceutical and medical goods Wavre · balance sheet €58.2m
- Kaneka Medical Europe Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €45.1m
- Amgen Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.6m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- S.A. Novo Nordisk Pharma N.V. Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet €67.2m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- Menarini Benelux Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €48.6m
Frequently asked questions about Eli Lilly European Clinical Trial Services
What is the revenue of Eli Lilly European Clinical Trial Services?
According to the 2025 annual accounts filed with the NBB, the revenue of Eli Lilly European Clinical Trial Services amounts to 270,436,467 €.
What is the VAT number of Eli Lilly European Clinical Trial Services?
In Belgium, the VAT number is the company number prefixed with BE: BE0888210786 for Eli Lilly European Clinical Trial Services, if the company is VAT-registered. Its company number (CBE) is 0888.210.786.
Where is the registered office of Eli Lilly European Clinical Trial Services?
According to the CBE register, the registered office of Eli Lilly European Clinical Trial Services is in 1435 Mont-Saint-Guibert.
What is the equity of Eli Lilly European Clinical Trial Services?
At the close of the 2025 financial year, the equity of Eli Lilly European Clinical Trial Services amounts to 4,955,701 €, a solvency of 8.6% of total assets.
How many people work at Eli Lilly European Clinical Trial Services?
32.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Eli Lilly European Clinical Trial Services?
The register lists 4 active mandates at Eli Lilly European Clinical Trial Services. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Eli Lilly European Clinical Trial Services within its sector?
By total assets for 2025, Eli Lilly European Clinical Trial Services ranks among the 10 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year.
The full file of Eli Lilly European Clinical Trial Services
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →